Objective: To explore the ideas and methods of clinical pharmacists regarding drug therapy for children with Kawasaki disease.
Methods: By participating in a whole drug treatment process for a child with Kawasaki disease, the rationality of the drug treatment plan was analyzed, pharmaceutical care was provided for the child, and a pharmaceutical care model suited to this child was developed.
Results: After treatment, the child was discharged from the hospital, and all signs and major inflammatory indicators returned to normal.